ArticleRisk analysis : an official publication of the Society for Risk Analysis2026
Robust Solar Radiation Modification Strategy for Achieving Temperature Targets.
Article in Risk analysis : an official publication of the Society for Risk Analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Solar radiation modification (SRM) provides an additional cooling option for limiting warming, but uncertainties about its realized cooling outcomes challenge the robustness of temperature-target strategies. This study develops an SRM decision framework that is robust in achieving the temperature target by embedding the min-max regret (MMR) rule into an integrated assessment model. We evaluate SRM strategies under uncertainty in cooling efficiency, SRM-related damages, and climate sensitivity. The results show that policies designed for adverse cooling-response states can better avoid temperature-target failure but generate great welfare losses from over-deployment. The MMR-based strategy exhibits distinct phasing, with restrained deployment before mid-century and accelerated deployment thereafter. Sensitivity analyses show that this two-phase pattern remains robust across alternative uncertainty sets. Overall, the robust framework balances the risk of temperature-target failure against the welfare cost of over-deployment under persistent uncertainties.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.